Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 2, 2017

Primary Completion Date

March 12, 2019

Study Completion Date

May 5, 2019

Conditions
Nasal Polyposis
Interventions
DRUG

Emthexate

After randomization, the patients were divided into three groups including 14 volunteers in each study groups and 11 in the control group. One of the study groups was take methotrexate (n=14, eight weeks) and the other was take methylprednisolone (n=14, eight week)

DRUG

Prednol

After randomization, the patients were divided into three groups including 14 volunteers in each study groups and 11 in the control group. One of the study groups was take methotrexate (n=14, eight weeks) and the other was take methylprednisolone (n=14, eight week)

DRUG

Mometasone Furoate

After randomization, the patients were divided into three groups including 14 volunteers in each study groups and 11 in the control group. One of the study groups was take methotrexate (n=14, eight weeks) and the other was take methylprednisolone (n=14, eight week)

Trial Locations (1)

35340

Dokuz Eylul University School of Medicine, Izmir

All Listed Sponsors
collaborator

The Scientific and Technological Research Council of Turkey

OTHER

lead

Dokuz Eylul University

OTHER

NCT04532736 - Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis | Biotech Hunter | Biotech Hunter